CX3CL1 and neoplasm: Using orthotopic syngeneic cancer cell lines in naturally occurring tumor immune microenvironments, we could observe the full capacity of chemokine CX3CL1 in cancer cells, immune cells, and tumor-supporting structures in the TME.